ATE534377T1 - Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen - Google Patents
Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungenInfo
- Publication number
- ATE534377T1 ATE534377T1 AT07794933T AT07794933T ATE534377T1 AT E534377 T1 ATE534377 T1 AT E534377T1 AT 07794933 T AT07794933 T AT 07794933T AT 07794933 T AT07794933 T AT 07794933T AT E534377 T1 ATE534377 T1 AT E534377T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- hematological diseases
- treating hematological
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80098306P | 2006-05-16 | 2006-05-16 | |
US83180506P | 2006-07-18 | 2006-07-18 | |
PCT/US2007/011726 WO2007136650A2 (en) | 2006-05-16 | 2007-05-16 | Method and compositions for treating hematological malignancies |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE534377T1 true ATE534377T1 (de) | 2011-12-15 |
Family
ID=38578698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07794933T ATE534377T1 (de) | 2006-05-16 | 2007-05-16 | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen |
Country Status (20)
Country | Link |
---|---|
US (3) | US20080039427A1 (de) |
EP (1) | EP2020996B1 (de) |
JP (2) | JP5544165B2 (de) |
KR (1) | KR101424832B1 (de) |
CN (1) | CN101442994B (de) |
AT (1) | ATE534377T1 (de) |
AU (1) | AU2007254309B2 (de) |
BR (1) | BRPI0711646C1 (de) |
CA (1) | CA2652048C (de) |
CY (1) | CY1112377T1 (de) |
DK (1) | DK2020996T3 (de) |
EA (1) | EA016995B1 (de) |
ES (1) | ES2377467T3 (de) |
HK (1) | HK1127913A1 (de) |
MX (1) | MX2008014665A (de) |
NZ (1) | NZ572368A (de) |
PL (1) | PL2020996T3 (de) |
PT (1) | PT2020996E (de) |
SI (1) | SI2020996T1 (de) |
WO (1) | WO2007136650A2 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
CN101437823B (zh) | 2006-05-04 | 2014-12-10 | 勃林格殷格翰国际有限公司 | 多晶型 |
EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
ATE534377T1 (de) * | 2006-05-16 | 2011-12-15 | Gilead Sciences Inc | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen |
TWI444384B (zh) | 2008-02-20 | 2014-07-11 | Gilead Sciences Inc | 核苷酸類似物及其在治療惡性腫瘤上的用途 |
PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
KR20110067096A (ko) | 2008-09-10 | 2011-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 및 관련 상태를 치료하기 위한 병용 요법 |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
KR20110103968A (ko) | 2008-12-23 | 2011-09-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 유기 화합물의 염 형태 |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
BR112012028136A2 (pt) | 2010-05-05 | 2016-08-09 | Boehringer Ingelheim Int | terapia de combinaçao |
KR20130093012A (ko) | 2010-06-24 | 2013-08-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
EP2731947B1 (de) | 2011-07-15 | 2019-01-16 | Boehringer Ingelheim International GmbH | Substituiertes dimeres chinazolin derivat, dessen herstellung und verwendung in pharmazeutischen zusammensetzungen zur behandlung von typ i und typ ii diabetes |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
CN103665043B (zh) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药及其在医药上的应用 |
ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
JP2021528363A (ja) * | 2018-06-12 | 2021-10-21 | シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド | ホスホンアミドエステル化合物、その塩、その関連する結晶体、その製造方法及びその使用 |
CN112168829B (zh) * | 2020-09-24 | 2022-02-15 | 华南理工大学 | 抗病毒药物在制备治疗骨髓增生异常综合征药物中的应用及制得的骨髓增生异常综合征药物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
AP1466A (en) | 2000-07-21 | 2005-09-22 | Gilead Sciences Inc | Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same. |
DE60221642T3 (de) * | 2001-02-12 | 2017-10-26 | Wyeth LLC (n.d.Ges.d. Staates Delaware) | O-desmethyl-venlafaxine succinat salz |
WO2003045394A1 (en) * | 2001-11-29 | 2003-06-05 | Pfizer Products Inc. | Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
NZ532436A (en) * | 2001-12-12 | 2006-01-27 | Pfizer Prod Inc | Salt forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
WO2004037161A2 (en) * | 2002-05-13 | 2004-05-06 | Metabasis Therapeutics, Inc. | Cyclic prodrugs of pmea one of its analogues |
US7563748B2 (en) | 2003-06-23 | 2009-07-21 | Cognis Ip Management Gmbh | Alcohol alkoxylate carriers for pesticide active ingredients |
US7767683B2 (en) * | 2003-08-18 | 2010-08-03 | H. Lundbeck A/S | Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament |
PT2204374E (pt) * | 2003-12-30 | 2012-09-17 | Gilead Sciences Inc | Fosfonatos nucleosídeos e seus análogos para o tratamento de infecções com hpv |
CA2553455A1 (en) | 2004-01-21 | 2005-08-11 | Gilead Sciences, Inc. | Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis |
DE102005041860A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen |
JP2009519952A (ja) * | 2005-12-16 | 2009-05-21 | ワイス | トリアゾロピリミジン化合物の凍結乾燥組成物 |
ATE534377T1 (de) * | 2006-05-16 | 2011-12-15 | Gilead Sciences Inc | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen |
-
2007
- 2007-05-16 AT AT07794933T patent/ATE534377T1/de active
- 2007-05-16 AU AU2007254309A patent/AU2007254309B2/en active Active
- 2007-05-16 EP EP07794933A patent/EP2020996B1/de active Active
- 2007-05-16 ES ES07794933T patent/ES2377467T3/es active Active
- 2007-05-16 US US11/803,822 patent/US20080039427A1/en not_active Abandoned
- 2007-05-16 SI SI200730862T patent/SI2020996T1/sl unknown
- 2007-05-16 PL PL07794933T patent/PL2020996T3/pl unknown
- 2007-05-16 CN CN200780017637XA patent/CN101442994B/zh active Active
- 2007-05-16 DK DK07794933.7T patent/DK2020996T3/da active
- 2007-05-16 WO PCT/US2007/011726 patent/WO2007136650A2/en active Application Filing
- 2007-05-16 CA CA2652048A patent/CA2652048C/en active Active
- 2007-05-16 MX MX2008014665A patent/MX2008014665A/es active IP Right Grant
- 2007-05-16 US US12/298,987 patent/US20090258840A1/en not_active Abandoned
- 2007-05-16 EA EA200802333A patent/EA016995B1/ru unknown
- 2007-05-16 JP JP2009511052A patent/JP5544165B2/ja active Active
- 2007-05-16 BR BRPI0711646A patent/BRPI0711646C1/pt active IP Right Grant
- 2007-05-16 NZ NZ572368A patent/NZ572368A/en unknown
- 2007-05-16 KR KR1020087030561A patent/KR101424832B1/ko active IP Right Grant
- 2007-05-16 PT PT07794933T patent/PT2020996E/pt unknown
-
2009
- 2009-08-10 HK HK09107295.8A patent/HK1127913A1/xx unknown
-
2011
- 2011-03-23 US US13/070,179 patent/US8435969B2/en active Active
-
2012
- 2012-02-16 CY CY20121100159T patent/CY1112377T1/el unknown
-
2013
- 2013-01-17 JP JP2013006055A patent/JP2013100324A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE534377T1 (de) | Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen | |
DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
EA200600689A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов raf киназы | |
EA201100447A1 (ru) | Органические соединения | |
ATE536349T1 (de) | In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
DE602005026508D1 (de) | Monozyklische heterozyklen als kinase-hemmer | |
EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
CO6270257A2 (es) | Derivados de piridazinona | |
EA200970935A1 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
DE602004012079D1 (de) | Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung | |
EA200802213A1 (ru) | Способы лечения заболеваний крови | |
DE602004019198D1 (de) | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege | |
EA200870089A1 (ru) | Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции | |
DE502005008058D1 (de) | Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
EA201000098A1 (ru) | Производные хиназолинамида | |
RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
EA201200087A1 (ru) | 2-карбоксамиды циклоаминомочевин, которые являются ингибиторами pi3k | |
SE0401969D0 (sv) | Piperidine derivatives | |
ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit | |
EA200701813A1 (ru) | Новые амидозамещенные 6-фенилфенантридины | |
EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения |